Corrigendum "Laboratory parameters identify familial haemophagocytic lymphohistiocytosis from other forms of paediatric haemophagocytosis" [British Journal of Haematology, 170(4), (2015), 532-538, DOI: 10.1111/bjh.13461];Laboratory parameters identify familial haemophagocytic lymphohistiocytosis from other forms of paediatric haemophagocytosis

British Journal of Haematology

Volumn 170, Issue 4, 2015, Pages 532-538

  Yasumi, Takahiro ^a   Hori, Masayuki ^a   Hiejima, Eitaro ^a   Shibata, Hirofumi ^a   Izawa, Kazushi ^a   Oda, Hirotsugu ^a,b   Yoshioka, Kouhei ^a   Nakagawa, Kenji ^a   Kawai, Tomoki ^a   Nishikomori, Ryuta ^a   Ohara, Osamu ^b,c   Heike, Toshio ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

^c KAZUSA DNA RESEARCH INSTITUTE   (Japan)

Author keywords

Common laboratory parameters; Differential diagnosis; Haemophagocytic lymphohistiocytosis; Innate and adaptive immunity

Indexed keywords

FERRITIN; LACTATE DEHYDROGENASE; SOLUBLE INTERLEUKIN 2 RECEPTOR; HYDROLYASE; INTERLEUKIN 2 RECEPTOR; LACTATE DEHYDRATASE;

ADAPTIVE IMMUNITY; ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; HEMOPHAGOCYTIC SYNDROME; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE DYSREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INNATE IMMUNITY; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOCYTE COUNT; MACROPHAGE ACTIVATION SYNDROME; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS; BLOOD; CLINICAL TRIAL; LEUKOCYTE COUNT; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FERRITINS; HUMANS; HYDRO-LYASES; INFANT; INFANT, NEWBORN; LEUKOCYTE COUNT; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; RECEPTORS, INTERLEUKIN-2;

EID: 84938550777     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13755     Document Type: Erratum

References (34)

1. Behrens, E.M., Beukelman, T., Paessler, M. & Cron, R.Q. (2007) Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. Journal of Rheumatology, 34, 1133-1138.
2. Bleesing, J., Prada, A., Siegel, D.M., Villanueva, J., Olson, J., Ilowite, N.T., Brunner, H.I., Griffin, T., Graham, T.B., Sherry, D.D., Passo, M.H., Ramanan, A.V., Filipovich, A. & Grom, A.A. (2007) The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis and Rheumatism, 56, 965-971.
3. Bode, S.F., Lehmberg, K., Maul-Pavicic, A., Vraetz, T., Janka, G., Stadt, U.Z. & Ehl, S. (2012) Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Research & Therapy, 14, 213.
4. Cohen, L.A., Gutierrez, L., Weiss, A., Leichtmann-Bardoogo, Y., Zhang, D.L., Crooks, D.R., Sougrat, R., Morgenstern, A., Galy, B., Hentze, M.W., Lazaro, F.J., Rouault, T.A. & Meyron-Holtz, E.G. (2010) Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood, 116, 1574-1584.
5. Davì, S., Minoia, F., Pistorio, A., Horne, A., Consolaro, A., Rosina, S., Bovis, F., Cimaz, R., Gamir, M.L., Ilowite, N.T., Kone-Paut, I., Feitosa de Oliveira, S.K., McCurdy, D., Silva, C.A., Sztajnbok, F., Tsitsami, E., Unsal, E., Weiss, J.E., Wulffraat, N., Abinun, M., Aggarwal, A., Apaz, M.T., Astigarraga, I., Corona, F., Cuttica, R., D'Angelo, G., Eisenstein, E.M., Hashad, S., Lepore, L., Mulaosmanovic, V., Nielsen, S., Prahalad, S., Rigante, D., Stanevicha, V., Sterba, G., Susic, G., Takei, S., Trauzeddel, R., Zletni, M., Ruperto, N., Martini, A., Cron, R.Q. & Ravelli, A.; Paediatric Rheumatology International Trials Organisation, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society. (2014) Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis & Rheumatology, 66, 2871-2880.
6. Henter, J.I., Horne, A., Aricó, M., Egeler, R.M., Filipovich, A.H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J. & Janka, G. (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer, 48, 124-131.
7. Janka, G.E. (2012) Familial and acquired hemophagocytic lymphohistiocytosis. Annual Review of Medicine, 63, 233-246.
8. + T cells and interferon gamma are essential for the disorder. Blood, 104, 735-743.
9. Kasahara, Y. & Yachie, A. (2002) Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Critical Reviews in Oncology Hematology, 44, 283-294.
10. Kawada, J., Kimura, H., Ito, Y., Ando, Y., Tanaka-Kitajima, N., Hayakawa, M., Nunoi, H., Endo, F. & Morishima, T. (2004) Evaluation of systemic inflammatory responses in neonates with herpes simplex virus infection. Journal of Infectious Diseases, 190, 494-498.
11. Kimura, H., Ito, Y., Kawabe, S., Gotoh, K., Takahashi, Y., Kojima, S., Naoe, T., Esaki, S., Kikuta, A., Sawada, A., Kawa, K., Ohshima, K. & Nakamura, S. (2012) EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood, 119, 673-686.
12. Kurt-Jones, E.A., Belko, J., Yu, C., Newburger, P.E., Wang, J., Chan, M., Knipe, D.M. & Finberg, R.W. (2005) The role of toll-like receptors in herpes simplex infection in neonates. Journal of Infectious Diseases, 191, 746-748.
13. Lehmberg, K., Pink, I., Eulenburg, C., Beutel, K., Maul-Pavicic, A. & Janka, G. (2013) Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis. Journal of Pediatrics, 162, 1245-1251.
14. Luo, Y.B. & Mastaglia, F.L. (2014) Dermatomyositis, polymyositis and immune-mediated necrotising myopathies. Biochimica et Biophysica Acta, 1852, 622-632.
15. Marsh, R.A., Bleesing, J.J. & Filipovich, A.H. (2010) Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency. Journal of Immunological Methods, 362, 1-9.
16. Murata, Y., Yasumi, T., Shirakawa, R., Izawa, K., Sakai, H., Abe, J., Tanaka, N., Kawai, T., Oshima, K., Saito, M., Nishikomori, R., Ohara, O., Ishii, E., Nakahata, T., Horiuchi, H. & Heike, T. (2011) Rapid diagnosis of familial hemophagocytic lymphohistiocytosis type 3 (FHL3) by flow cytometric detection of intraplatelet Munc13-4 protein. Blood, 118, 1225-1230.
17. Norvell, J.P., Blei, A.T., Jovanovic, B.D. & Levitsky, J. (2007) Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases. Liver Transplantation, 13, 1428-1434.
18. Papathanassoglou, E.D., Moynihan, J.A. & Ackerman, M.H. (2000) Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and a theoretical framework. Critical Care Medicine, 28, 537-549.
19. Ravelli, A., Magni-Manzoni, S., Pistorio, A., Besana, C., Foti, T., Ruperto, N., Viola, S. & Martini, A. (2005) Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Journal of Pediatrics, 146, 598-604.
20. Rosado, F.G. & Kim, A.S. (2013) Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. American Journal of Clinical Pathology, 139, 713-727.
21. Rubin, L.A. & Nelson, D.L. (1990) The soluble interleukin-2 receptor: biology, function, and clinical application. Annals of Internal Medicine, 113, 619-627.
22. de Saint Basile, G., Ménasché, G. & Latour, S. (2011) Inherited defects causing hemophagocytic lymphohistiocytic syndrome. Annals of the New York Academy of Sciences, 1246, 64-76.
23. Shimizu, M., Yokoyama, T., Yamada, K., Kaneda, H., Wada, H., Wada, T., Toma, T., Ohta, K., Kasahara, Y. & Yachie, A. (2010) Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford), 49, 1645-1653.
24. Suzuki, N., Morimoto, A., Ohga, S., Kudo, K., Ishida, Y. & Ishii, E.; HLH/LCH Committee of the Japanese Society of Pediatric Hematology. (2009) Characteristics of hemophagocytic lymphohistiocytosis in neonates: a nationwide survey in Japan. Journal of Pediatrics, 155, 235-238.e231.
25. Tabata, C. & Tabata, R. (2012) Possible prediction of underlying lymphoma by high sIL-2R/ferritin ratio in hemophagocytic syndrome. Annals of Hematology, 91, 63-71.
26. Tacke, F., Luedde, T. & Trautwein, C. (2009) Inflammatory pathways in liver homeostasis and liver injury. Clinical Reviews in Allergy and Immunology, 36, 4-12.
27. Tsuji, T., Hirano, T., Yamasaki, H., Tsuji, M. & Tsuda, H. (2014) A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome. Annals of Hematology, 93, 821-826.
28. Vastert, S.J., Kuis, W. & Grom, A.A. (2009) Systemic JIA: new developments in the understanding of the pathophysiology and therapy. Best Practice & Research. Clinical Rheumatology, 23, 655-664.
29. Veillette, A., Pérez-Quintero, L.A. & Latour, S. (2013) X-linked lymphoproliferative syndromes and related autosomal recessive disorders. Current opinion in Allergy and Clinical Immunology, 13, 614-622.
30. Villanueva, J., Lee, S., Giannini, E.H., Graham, T.B., Passo, M.H., Filipovich, A. & Grom, A.A. (2005) Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Research & Therapy, 7, R30-R37.
31. Wittkowski, H., Frosch, M., Wulffraat, N., Goldbach-Mansky, R., Kallinich, T., Kuemmerle-Deschner, J., Frühwald, M.C., Dassmann, S., Pham, T.H., Roth, J. & Foell, D. (2008) S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis and Rheumatism, 58, 3924-3931.
32. Yang, X., Kanegane, H., Nishida, N., Imamura, T., Hamamoto, K., Miyashita, R., Imai, K., Nonoyama, S., Sanayama, K., Yamaide, A., Kato, F., Nagai, K., Ishii, E., van Zelm, M.C., Latour, S., Zhao, X.D. & Miyawaki, T. (2012) Clinical and genetic characteristics of XIAP deficiency in Japan. Journal of Clinical Immunology, 32, 411-420.
33. Zhang, M., Behrens, E.M., Atkinson, T.P., Shakoory, B., Grom, A.A. & Cron, R.Q. (2014) Genetic defects in cytolysis in macrophage activation syndrome. Current Rheumatology Reports, 16, 439.
34. Zhao, M., Kanegane, H., Kobayashi, C., Nakazawa, Y., Ishii, E., Kasai, M., Terui, K., Gocho, Y., Imai, K., Kiyasu, J., Nonoyama, S. & Miyawaki, T. (2011) Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry. Cytometry. Part B, Clinical Cytometry, 80, 8-13.